Direitos de propriedade industrial e acesso a medicamentos para o tratamento da AIDS no Brasil
O Acordo TRIPS, que entrou em vigor em 1o de janeiro de 1995, obriga os Estados-membros da OMC a reconhecerem a patente de produtos e processos farmacêuticos, proibindo assim que sejam copiados, uma prática comum em certos países que adotam políticas de ...
Amélie Robine
doaj
Aptamers as a novel diagnostic and therapeutic tool and their potential use in parasitology [PDF]
Ospina JD.
europepmc +1 more source
Open Innovation in firms located in an intermediate technology developed country [PDF]
Open Innovation is a flow of inputs and outputs of knowledge and technology which favours, at the firm level, the acceleration of the innovation process, as well as the establishment and penetration of firms in new markets.
Aurora A.C. Teixeira, Mariana Lopes
core
[Extension of the term of validity of pharmaceutical patents by lawsuits: effects on centralized procurement and the private market]. [PDF]
Paranhos J +4 more
europepmc +1 more source
[Penicillin: from discovery to patenting the large-scale production process]. [PDF]
Silva RVD +2 more
europepmc +1 more source
["If you are a woman, read this, it's good for you": the advertising of medicines targeted at mothers in the Colombian press, 1903-1945]. [PDF]
Agudelo-González ÁL.
europepmc +1 more source
The case of eculizumab: litigation and purchases by the Brazilian Ministry of Health. [PDF]
Caetano R +4 more
europepmc +1 more source
The elimination of HIV/AIDS depends on prevention and treatment strategies that address health inequalities. [PDF]
Magno L.
europepmc +1 more source
[Judicial recourse and access to health technologies: opportunities and risksJudicialização e acesso a tecnologias em saúde: oportunidades e riscos]. [PDF]
Vidal J, Di Fabio YJL.
europepmc +1 more source

